- Home
- GALT vs BRY Comparison
GALT vs BRY Comparison
Compare GALT & BRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- BRY
- Stock Information
- Founded
- GALT 2000
- BRY 1909
- Country
- GALT United States
- BRY United States
- Employees
- GALT N/A
- BRY N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- BRY Oil & Gas Production
- Sector
- GALT Health Care
- BRY Energy
- Exchange
- GALT Nasdaq
- BRY Nasdaq
- Market Cap
- GALT 232.3M
- BRY 249.1M
- IPO Year
- GALT N/A
- BRY N/A
- Fundamental
- Price
- GALT $5.49
- BRY $3.32
- Analyst Decision
- GALT Strong Buy
- BRY Hold
- Analyst Count
- GALT 3
- BRY 2
- Target Price
- GALT $6.00
- BRY $4.00
- AVG Volume (30 Days)
- GALT 443.8K
- BRY 705.3K
- Earning Date
- GALT 11-14-2025
- BRY 11-05-2025
- Dividend Yield
- GALT N/A
- BRY 3.61%
- EPS Growth
- GALT N/A
- BRY N/A
- EPS
- GALT N/A
- BRY N/A
- Revenue
- GALT N/A
- BRY $730,290,000.00
- Revenue This Year
- GALT N/A
- BRY N/A
- Revenue Next Year
- GALT N/A
- BRY N/A
- P/E Ratio
- GALT N/A
- BRY N/A
- Revenue Growth
- GALT N/A
- BRY N/A
- 52 Week Low
- GALT $0.73
- BRY $2.11
- 52 Week High
- GALT $6.55
- BRY $5.09
- Technical
- Relative Strength Index (RSI)
- GALT 51.59
- BRY 43.49
- Support Level
- GALT $5.23
- BRY $3.23
- Resistance Level
- GALT $6.32
- BRY $3.48
- Average True Range (ATR)
- GALT 0.55
- BRY 0.12
- MACD
- GALT -0.05
- BRY -0.00
- Stochastic Oscillator
- GALT 36.22
- BRY 28.12
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About BRY Berry Corporation (bry)
Berry Corp (bry) is a western United States independent upstream energy company with a focus on the conventional, long-lived oil reserves in the San Joaquin basin of California. Its operating segments includes Exploration and Production (E&P) and Well Servicing and Abandonment. The company generates maximum revenue from the Exploration and Production (E&P) segment.